{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:37:36Z","timestamp":1790789856023,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.4158\/ep14162.cr","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased Chromogranin a and Carcinoid Syndrome-Like Symptons in a Patient Treated with Duloxetine"],"prefix":"10.1016","volume":"20","author":[{"given":"Stefan","family":"Karger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Kersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Wurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Kratzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stumvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Fasshauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14162.CR_bb0005","first-page":"2622","article-title":"Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones","volume":"82","author":"Nobels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP14162.CR_bb0010","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/BF03345347","article-title":"Adrenal incidentaloma diagnosed as pheochromocytoma by plasma chromogranin A and plasma metanephrines","volume":"28","author":"Miehle","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP14162.CR_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/eci.12245","article-title":"Clinical utility of chromogranin A in SDHx-related paragangliomas","volume":"44","author":"Zuber","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP14162.CR_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/cancers4010141","article-title":"Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review","volume":"4","author":"N\u00f6lting","year":"2012","journal-title":"Cancers (Basel)"},{"key":"10.4158\/EP14162.CR_bb0025","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/clinchem\/38.11.2267","article-title":"Immunoluminometric assay of chromogranin A in serum with commercially available reagents","volume":"38","author":"Bender","year":"1992","journal-title":"Clin Chem"},{"key":"10.4158\/EP14162.CR_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.2001.2977","article-title":"Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality","volume":"23","author":"Ceconi","year":"2002","journal-title":"Eur Heart J"},{"key":"10.4158\/EP14162.CR_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/00044011-200626120-00005","article-title":"Evaluation of chromogranin A expression in patients with non-neuroendocrine tumours","volume":"26","author":"Tropea","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.4158\/EP14162.CR_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/eje.0.1500299","article-title":"Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man","volume":"150","author":"Giusti","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP14162.CR_bb0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.1995.457","article-title":"Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies","volume":"72","author":"Cubeddu","year":"1995","journal-title":"Br J Cancer"},{"key":"10.4158\/EP14162.CR_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00365520701561959","article-title":"Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition","volume":"43","author":"Fossmark","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.4158\/EP14162.CR_bb0055","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"10.4158\/EP14162.CR_bb0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pharmthera.2005.06.004","article-title":"Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan","volume":"109","author":"Turner","year":"2006","journal-title":"Pharmacol Ther."},{"key":"10.4158\/EP14162.CR_bb0065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.4158\/EP14162.CR_bb0070","series-title":"Antidepressants: Past, Present and Future","first-page":"241","article-title":"Selective serotonin reuptake inhibitors","author":"Preskorn","year":"2004"},{"key":"10.4158\/EP14162.CR_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-2008-1058103","article-title":"Treatment of seasonal affective disorder with duloxetine: an open label study","volume":"41","author":"Pjrek","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.4158\/EP14162.CR_bb0080","series-title":"Eli Lilly Canada Inc","first-page":"1","author":"Monograph","year":"2011"},{"key":"10.4158\/EP14162.CR_bb0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0306-4522(95)00275-N","article-title":"Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain","volume":"69","author":"Kroesen","year":"1995","journal-title":"Neuroscience"},{"key":"10.4158\/EP14162.CR_bb0090","unstructured":"Budharaju VG, Dillon J, Shibli-Rahhal A. Duloxetine induced false positive testing for pheochromocytoma. In: Program of the 20th annual meeting of the AACE, April 13-17, 2011; San Diego, CA. Abstract #111."},{"key":"10.4158\/EP14162.CR_bb0095","article-title":"Carbamazepine for acute and chronic pain in adults","volume":"19","author":"Wiffen","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"10.4158\/EP14162.CR_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/09637480802558508","article-title":"Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans: assessment of stress using heart rate variability and salivary chromogranin A","volume":"60","author":"Nakamura","year":"2009","journal-title":"Int J Food Sci Nutr"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/A61760320172211N.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:16Z","timestamp":1761515836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20419263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1530891X20419263"],"URL":"https:\/\/doi.org\/10.4158\/ep14162.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Chromogranin a and Carcinoid Syndrome-Like Symptons in a Patient Treated with Duloxetine","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14162.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}